NorthWest Biotherapeutics Inc (NWBO)

[CaptainObvious]

I've stated this concern since the Cognate days. No good answer yet, except that maybe NWBO is not allowed to profit on specials. I would imagine that stated costs from Advent could be, uh, inflated, so that Advent/Toucan/whoever is making the $$.

If that's the case, will the cost structure remain the same once NWBO gets approval? The precedent would be there for it.

If so, the value of Advent could be shown to be much higher than NWBO based on income, with accounting tricks maybe.

If that's the case then any merger with Advent/NWBO/etc. could give LP 51%+ control over the merged entities.

In this case it would be in the best interest to not let the sp of NWBO get out of control. Keep the MC down. How would you do that? I dunno, no communication, fumbled PR's, missed deadlines, vague timelines, things like that, along with help from the inevitable shorters.

That would be a smart move, if one had a cynical mindset, and very little conscience.

The good news is longs might get enough of a return to be happy they got something, and keep their mouths shut, and a new cancer treatment becomes available to the public.

It's a win/didn't lose everything situation